| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Giladi Moshe | Chief Science Officer | Feb 27, 2024 | Option Exercise | $16.30 | 51,124 | 833,321 | 69,771 | Feb 29, 2024, 04:33 PM |
Menu
| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Giladi Moshe | Chief Science Officer | Feb 27, 2024 | Option Exercise | $16.30 | 51,124 | 833,321 | 69,771 | Feb 29, 2024, 04:33 PM |